| 书目名称 | Probiotic Research in Therapeutics | | 副标题 | Volume 5: Metabolic | | 编辑 | Indu Pal Kaur (Editor-in-Chief),Kanwaljit Chopra,K | | 视频video | | | 概述 | Discusses the use of probiotics in type 1 and 2 diabetes, obesity, metabolic endotoxemia, and liver disorders.Explains mechanism of action and growing status of probiotics as therapeutic strategies in | | 图书封面 |  | | 描述 | This volume focuses on the potential use of probiotics in treating metabolic disorders such as diabetes mellitus, metabolic acidosis, and gut dysbiosis. Chapters draw an association between gut microbiota and its diversity with metabolic diseases like diabetes, obesity, related liver and gut disorders; gut-brain axis; increased inflammation, and a compromised immune system resulting from these manifestations and scope of intervention with probiotics. Special attention is laid on describing the mechanisms of action of such beneficial effects of probiotic administration. The ability of probiotics to decrease metabolic endotoxemia by restoring the disrupted intestinal mucosal barrier is also included..The volume is a comprehensive compilation describing the scope and application of probiotic and prebiotic therapy in treating metabolic disorders. Readers will discover how probiotics are not just confined to the microbiology industry but are showing promising results in the medical and pharmaceutical sectors.. | | 出版日期 | Book 2022 | | 关键词 | Gut Dysbiosis; Metabolic Acidosis; Metabolic Endotoxemia; Designer Probiotics; Safety Concerns; Regulator | | 版次 | 1 | | doi | https://doi.org/10.1007/978-981-16-8444-9 | | isbn_softcover | 978-981-16-8446-3 | | isbn_ebook | 978-981-16-8444-9 | | copyright | Springer Nature Singapore Pte Ltd. 2022 |
The information of publication is updating
|
|
发表于 2025-3-21 19:41:48
